Bank of America Securities analyst Alec Stranahan reiterated a Buy rating on RegenXBio (RGNX – Research Report) today and set a price target of ...
H.C. Wainwright lowered the firm’s price target on Regenxbio (RGNX) to $34 from $36 and keeps a Buy rating on the shares following the Q4 results. Published first on TheFly – the ultimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results